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Excluded: 439 Patients  
Did not meet inclusion criteria:  52  
                 Refused to participate: 177 
                 Recruitment window closed:  210 
 
Invited to take part, (reported as eligible by team leader):  
198 MHNs 
Excluded: 138 MHNs 
Did not respond to invitation: 131 
Consented but withdrew before randomisation. 7                                       
(personal, workload and new job reasons.) 
Randomised 60 MHNs, 173 Patients  
29 MHNs allocated 
4 Did not recruit any patients  
26 Received HIP Training (n=84 patients) 
3 Withdrew before Training: (n=6 patients)  
27 (93%) completed baseline adapted PHASe 





















MHN =Mental Health Nurse, PHASe = adapted Physical Health Attitude Survey, (adapted includes knowledge questions), LTFU = Lost to follow-up. SF36v2 PCS – Short Form 36 version 2 Physical Health 
Component, ITT = Intention to Treat 
	
Invited to take part, (on consented nurse caseload and reported as eligible): 
  612 patients 
90 Patients allocated 
1 withdrew (after consent & before baseline) 
86 completed baseline SF36v2 PCS 
38 (42%) completed baseline HIPs  
                                (n=13 MHNs)  
 
83 Patients 
82 completed baseline SF36v2 PCS 
 4 (5%) completed baseline HIPs 
(n=1 MHN) 
 
31 MHNs allocated 
5 Did not recruit any patients 
1 Received HIP training in error (n=4 patients) 
24 (77%) completed baseline adapted PHASe 
 1 (3%) completed baseline HIPs  
62 Patients 
13 (15.7%) LTFU, 8  (9.6%) Withdrew 
61 (73.4%) completed SF36v2 PCS 
2 (2%) completed HIP (n= 1 MHN) 
 
60 Patients 
(PCS BL and follow-up) 
 
TREATMENT AS USUAL HIP PROGRAMME GROUP 
           26 MHN  
0 LTFU, 0 Withdrew 
8 (27%) completed adapted PHASe 
8 (28%) completed HIPs (n= 22 patients)  
25 MHN clusters 
 
68 Patients 
(PCS at BL and follow-up) 
 
70 patients 
10 (11%) LTFU, 9 (11%) Withdrew  
70 (77%) completed SF36v2 PCS 
22 (24%) completed HIPs (n= 8 MHNs) 
30 MHN 
1 (3%) LTFU:( n = 3 patients), 0 Withdrew 
13 (42%) completed adapted PHASe  
1 (3%) completed HIP (n= 2 patients)  
 
24 MHN Clusters 
 
Figure 1, participant flow through the trial 
	
 
Table 1, Characteristics of nurses at baseline    
 HIP (N=29) Treatment as usual (N=31) 
Characteristic N % N % 
Service       
Recovery 18 62 18 58 
Assertive Outreach 9 31 10 32 
Rehabilitation 1 3 0 0 
Forensic 1 3 3 10 
Age in years (mean, SD) 46.5±7.5  44.8±8.9  
Gender (female) 22 76 21 68 
Ethnicity (white British) 28 97 25 81 
NHS clinical band 6  27 93 26 84 
Highest academic qualification                
Certificate 6 21 7 23 
Diploma 14 48 12 39 
Degree 7 24 9 29 
Masters 2 7 3 10 
Years of mental health clinical 
experience (mean, SD) 
16.5±9.6  14.16±7.7  
Time in current post      
Less than 1 year 3 10 3 10 
1 to less than 5 years 12 41 11 36 
5 to less than 10 years 10 35 13 42 
10 or more years 4 14 4 13 
















Table 2. Patient demographic and clinical characteristics at baseline 
 
 HIP (n=90) Treatment as usual (n=83) 
Characteristic N % N % 
Diagnosis*     
Schizophrenia 52 58 58 70 
Schizoaffective disorder 7 8 6 7 
Bipolar Disorder 30 33 18 22 
Other 0 0 1 1 
Age in years (mean, SD)* 47.6±11.52  45.1±12.6  
Gender (male)* 46 51  50 60 
Ethnicity (white British) 80 89 76 92 
Lives alone* 49 54 48 58 
Single, divorced or 
widowed 59 66 58 70 
Smokes cigarettes* 59 66 48 58 
Medical comorbidities*     
None 23 26 19 23 
1-4 57 63 58 70 
5 or more 6 7 6 7 
Number of medications 
(median, range) 4 (0-18)  4 (0-20)  
Number of antipsychotics*     
Zero 3 3 10 12 
1 65 72 60 72 
2 or more 15 17 11 13 
Prescribed atypical 
antipsychotic* 63 70 49 59 
Prescribed typical 
antipsychotic* 24 27 27 33 
Family history of 
cardiovascular disease 19 21 25 30 
Prescribed medicines for 
cardiovascular disease** 24 27 22 27 
SF 36v2 PCS baseline 
(mean, SD)1 43.2±11.0  45.1±11.94  
SF36v2 MCS baseline 
(mean, SD)2 39.2±14.01  
36.92±14.3  
*potential covariate 
**includes medications for diabetes, dyslipidaemia and hypertension  
1. SF-36v2 (PCS) Physical Component Scale, range 0-100, a higher score indicates better 
physical wellbeing 




Table 3. Number of reported serious adverse events (SAEs)  
 
 HIP Treatment as usual 
Deaths 1 2 
Self-harm 1 0 
Psychiatric admissions 11 11 
General hospital admissions 3 7 
Other serious medical conditions 1 1 
Total SAEs 17 21 
 
 
 
